An antisense therapy that targets a glycine transporter restored NMDA receptor function in mouse models related to autism and in human brain organoids. An overlooked protein that regulates levels of the amino acid glycine may hold the key to treating autism and other disorders linked to disrupted brain signaling. Researchers at the Institute for Basic [...]from SciTechDaily https://ift.tt/afVs4cp
